Provider review
LunaRx review
The only provider here whose pitch is coming off the drug.
Off-ramp care and muscle-protective stacks are priced as products rather than mentioned as ideas.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
LunaRx
From $149/mo base, $199/mo with muscle-protective stacks
- Vs median
- $20/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A referenced
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Almost every provider in this category sells a prescription that continues. This one sells recomposition and an exit, and says so in the sentence that introduces itself: metabolic recomposition, not another forever prescription. If you arrived here intending to take a small dose, protect what muscle you have and then stop, that is the whole proposition rather than a footnote — and the muscle-protective stack is priced as its own upgrade rather than assumed into the base plan. The site is published in Spanish as well as English, which is uncommon enough to matter. The pricing is ordinary by comparison. Both figures are floors with nothing above either published, and four-week language appears on the site without being attached to any particular figure, which is worth confirming before starting since a four-week month means thirteen charges a year rather than twelve. No milligram appears against either program.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You intend to come off the drug and want that planned rather than improvised
- You want lean-mass protection priced as its own thing
- You want the site and the care available in Spanish
Look elsewhere if
- You want a published rate rather than a floor
- You want the billing cadence pinned to the figure
- You want a dose behind the number
What it actually costs
Price as published
★ THE PITCH IS THE OPPOSITE OF EVERY OTHER ROW HERE — "Metabolic recomposition, not another forever prescription", with off-ramp care named alongside the GLP-1 itself · "Precision GLP-1 + muscle-protective stacks from $199/mo" is the headline, with a second figure "from $149/mo" for the base program · lean-mass protection and a planned exit are both product features rather than afterthoughts, which matters to a reader whose intention is to take a small dose and stop · "No insurance needed. Cancel anytime · $0 if not approved" is stated together · the site is published in English and Spanish, and the 503A class is referenced three times · both figures are floors, four-week cadence language appears on the site, and no milligram is published
- Vs median
- $20/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ Alone among the rows here, the proposition is coming OFF the drug rather than staying on it — recomposition and off-ramp care are named products, and lean-mass protection is priced as its own upgrade rather than assumed. That is the shape a reader taking a small dose with an exit in mind actually wants. No low-dose product is priced, both figures are floors, and four-week language appears without being pinned to a figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Frames the program around recomposition and a planned exit rather than continuation.
- Prices the muscle-protective stack as its own upgrade rather than assuming it.
- Published in English and Spanish, with no charge if an intake ends in a decline.
Pharmacy, labs and oversight
LunaRx dispenses through a 503A referenced facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What LunaRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Almost every provider in this category sells a prescription that continues. This one sells recomposition and an off-ramp, and says so in the sentence that introduces itself: metabolic recomposition, not another forever prescription. For a reader who arrives here intending to take a small dose, protect lean mass and stop, that is the whole proposition rather than a footnote, and the muscle-protective stack is priced as its own upgrade rather than assumed. It is also bilingual, which is rare enough to matter. The pricing is ordinary by comparison. Both figures are floors, nothing above either is published, and four-week language appears on the site without the cadence being pinned to any particular figure — which is the sort of detail worth confirming before starting, since a four-week month is thirteen charges a year. No milligram appears against either program.
The honest cons
Both figures are floors with nothing above either published.
- Four-week cadence language appears without being attached to a specific figure.
- No milligram appears against either program.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
LunaRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#353 of 373
Ordered with the companies that pay us first, and LunaRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.